Form 4: Anterix Inc. Executive Chairman Exercises Stock Options and Sells Shares

Anterix Inc.'s Executive Chairman, Morgan E. O'Brien, exercised stock options and sold shares on December 9, 2024.

Summary

• Morgan E. O'Brien, the Executive Chairman of Anterix Inc., engaged in multiple transactions involving the company's stock on December 9, 2024.
• He acquired 90,000 shares of common stock through the exercise of stock options.
• These options were fully vested and would have expired on January 29, 2025.
• O'Brien also sold 76,391 shares of common stock at a price of $34.05 per share.
• The sale of shares resulted in a total value of $2,601,913.55.
• The price of $34.05 reflects the closing price of Anterix's common stock on the Nasdaq Capital Market on December 9, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no indication of positive or negative sentiment. It is a routine disclosure.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of key executives.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice in publicly traded companies, particularly in the technology sector.
• The timing and volume of these transactions are often scrutinized by investors for insights into management's view of the company's prospects.
• Similar transactions are regularly reported by executives at companies like Verizon, AT&T, and T-Mobile, which are also in the telecommunications space.

Stakeholder Impact

• The transaction may have a minor impact on the stock price due to the sale of shares by a key executive.
• Shareholders will be informed of the transaction through this disclosure.

Key Dates

Keywords

Anterix Inc., stock options, common stock, executive chairman, insider trading, ATEX, Nasdaq